News
New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot that can protect babies from respiratory syncytial virus, adding an additional tool against the most common cause of hospitalization in infants.
2don MSN
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
MedPage Today on MSN2d
Kennedy's ACIP Backs Monoclonal Antibody for RSV Prevention in InfantsThe CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...
Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...
Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...
RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...
A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback